Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular ...

Adults with pulmonary arterial hypertension using vs. not using GLP-1 receptor agonists had significantly lower relative ...

People without diabetes who receive GLP-1 receptor agonists for the treatment of overweight or obesity face a reduced risk of ...

A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

A large real-world analysis of 1.8 million patients found that type 2 diabetes patients with sleep apnea gained a 20% greater ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.

GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...

Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

CuraSen Therapeutics has commenced its Phase IIa proof-of-concept trial of CuraAX (CST-3056) with dosing of the first patient ...